av/cymabay-therapeutics--big.svg

COM:CYMABAY

CymaBay Therapeutics Inc

  • Stock

USD

Last Close

32.47

21/03 20:00

Market Cap

3.73B

Beta: -

Volume Today

8.35M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
10M
-
31.07M
-
cost of revenue
681K
-
gross profit
10M
-
30.39M
-
selling and marketing expenses
general and administrative expenses
4.87M
-
8.19M
68.04%
8.87M
8.38%
9.64M
8.73%
12.39M
28.43%
14.38M
16.10%
19.24M
33.77%
17.43M
9.42%
23.04M
32.22%
25.12M
9.01%
51.95M
106.85%
selling general and administrative expenses
4.87M
-
8.19M
68.04%
8.87M
8.38%
9.64M
8.73%
12.39M
28.43%
14.38M
16.10%
19.24M
33.77%
17.43M
9.42%
23.04M
32.22%
25.12M
9.01%
51.95M
106.85%
research and development expenses
4.53M
-
15.82M
249.68%
17.03M
7.60%
15.94M
6.37%
18.94M
18.80%
58.12M
206.92%
83.84M
44.24%
35.88M
57.20%
64.54M
79.87%
68.00M
5.35%
80.12M
17.83%
other expenses
135K
-
-7.23M
5,454.07%
11.12M
253.86%
76K
99.32%
-5.77M
7,696.05%
-3.29M
43.05%
5.08M
254.35%
1.76M
-
cost and expenses
9.40M
-
24.01M
155.51%
25.90M
7.87%
25.59M
1.20%
31.32M
22.43%
72.50M
131.46%
103.08M
42.16%
53.31M
48.28%
87.58M
64.30%
93.11M
6.31%
132.75M
42.57%
operating expenses
9.40M
-
24.01M
155.51%
25.90M
7.87%
25.59M
1.20%
31.32M
22.43%
72.50M
131.46%
103.08M
42.16%
53.31M
48.28%
87.58M
64.30%
93.11M
6.31%
132.07M
41.84%
interest expense
822K
-
755K
8.15%
913K
20.93%
1.34M
46.44%
1.08M
19.22%
336K
68.89%
2.58M
-
14.91M
477.12%
18.95M
27.09%
ebitda
-9.20M
-
-31.14M
238.67%
-14.59M
53.14%
-25.30M
73.39%
-26.44M
4.49%
-71.70M
171.16%
-97.73M
36.31%
-53.38M
45.38%
-86.73M
62.47%
-91.09M
5.04%
-101.00M
10.87%
operating income
-9.40M
-
-24.01M
155.51%
-25.90M
7.87%
-25.59M
1.20%
-21.32M
16.65%
-72.50M
240%
-108.15M
49.16%
-52.60M
51.36%
-87.58M
66.50%
-93.11M
6.31%
-101.68M
9.20%
depreciation and amortization
55K
-
18K
67.27%
22K
22.22%
29K
31.82%
35K
20.69%
105K
200%
10.42M
9,820.95%
-778K
107.47%
855K
209.90%
2.02M
135.91%
681K
66.24%
total other income expenses net
135K
-
-7.23M
5,454.07%
11.12M
253.86%
76K
99.32%
-5.77M
7,696.05%
-3.69M
36.00%
5.34M
244.57%
1.62M
69.75%
-2.42M
249.50%
-12.89M
433.53%
-3.69M
71.37%
income before tax
-10.07M
-
-31.92M
216.86%
-15.53M
51.35%
-26.67M
71.75%
-27.56M
3.32%
-72.55M
163.27%
-102.81M
41.71%
-50.99M
50.41%
-90.00M
76.52%
-106.00M
17.78%
-105.37M
0.60%
income tax expense
957K
-
-6.47M
776.38%
12.03M
285.91%
1.41M
88.26%
-4.69M
432.13%
293K
106.24%
-572K
295.22%
-2.32M
305.77%
2.58M
211.29%
12.89M
399.03%
net income
-10.07M
-
-31.92M
216.86%
-15.53M
51.35%
-26.67M
71.75%
-27.56M
3.32%
-72.55M
163.27%
-102.24M
40.92%
-48.66M
52.40%
-92.58M
90.24%
-118.89M
28.42%
-105.37M
11.37%
weighted average shs out
14.06M
-
12.05M
14.33%
18.90M
56.86%
23.45M
24.06%
34.90M
48.86%
57.81M
65.62%
67.03M
15.96%
68.89M
2.77%
71.06M
3.14%
87.80M
23.57%
106.20M
20.96%
weighted average shs out dil
14.06M
-
12.05M
14.33%
18.92M
57.00%
23.45M
23.95%
34.90M
48.86%
57.84M
65.71%
67.03M
15.90%
68.89M
2.77%
71.06M
3.14%
87.80M
23.57%
106.20M
20.96%
eps
-0.72
-
-2.65
268.06%
-0.82
69.06%
-1.14
39.02%
-0.79
30.70%
-1.25
58.23%
-1.53
22.40%
-0.71
53.59%
-1.30
83.10%
-1.35
3.85%
-0.99
26.67%
epsdiluted
-0.72
-
-2.65
268.06%
-0.82
69.06%
-1.14
39.02%
-0.79
30.70%
-1.25
58.23%
-1.53
22.40%
-0.71
53.59%
-1.30
83.10%
-1.35
3.85%
-0.99
26.67%

All numbers in USD (except ratios and percentages)